Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships-Reference-Cited by-同舟云学术

Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships

Published:2013-09-22 Issue:4 Volume:2 Page:413-425
ISSN:1948-7894
Container-title:Journal of Radiation Oncology
language:en
Short-container-title:J Radiat Oncol

Author:

Dholakia Avani S.,Hacker-Prietz Amy,Wild Aaron T.,Raman Siva P.,Wood Laura D.,Huang Peng,Laheru Daniel A.,Zheng Lei,De Jesus-Acosta Ana,Le Dung T.,Schulick Richard,Edil Barish,Ellsworth Susannah,Pawlik Timothy M.,Iacobuzio-Donahue Christine A.,Hruban Ralph H.,Cameron John L.,Fishman Elliot K.,Wolfgang Christopher L.,Herman Joseph M.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s13566-013-0115-6.pdf

Reference34 articles.

1. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733. doi: 10.1245/s10434-009-0408-6

2. Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA (2012) Pancreatic adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Cancer Netw 10:703–713

3. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833–846. doi: 10.1016/j.jamcollsurg.2007.12.020

4. van Geenen RC, ten Kate FJ, de Wit LT, van Gulik TM, Obertop H, Gouma DJ (2001) Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 129:158–163. doi: 10.1067/msy.2001.110221

5. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, Lee JE, Pisters PW, Evans DB, Wolff RA (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046. doi: 10.1245/ASO.2006.08.011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic ductal adenocarcinoma;Insights into Imaging;2024-07-25

2. Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?;Cancers;2024-06-30

3. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study;British Journal of Surgery;2024-03

4. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer;Nature Reviews Gastroenterology & Hepatology;2023-11-30

5. Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy;HPB;2023-09